114 related articles for article (PubMed ID: 21292643)
1. Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study.
Toriola AT; Grankvist K; Agborsangaya CB; Lukanova A; Lehtinen M; Surcel HM
Ann Oncol; 2011 Aug; 22(8):1916-21. PubMed ID: 21292643
[TBL] [Abstract][Full Text] [Related]
2. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC; Mallen AR; Townsend MK; Poole EM; Trabert B; Allen NE; Arslan AA; Dossus L; Fortner RT; Gram IT; Hartge P; Idahl A; Kaaks R; Kvaskoff M; Magliocco AM; Merritt MA; Quirós JR; Tjonneland A; Trichopoulou A; Tumino R; van Gils CH; Visvanathan K; Wentzensen N; Zeleniuch-Jacquotte A; Tworoger SS
Cancer Res; 2019 Oct; 79(20):5442-5451. PubMed ID: 31462430
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
Toriola AT; Surcel HM; Agborsangaya C; Grankvist K; Tuohimaa P; Toniolo P; Lukanova A; Pukkala E; Lehtinen M
Eur J Cancer; 2010 Jan; 46(2):364-9. PubMed ID: 19713101
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
6. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
[TBL] [Abstract][Full Text] [Related]
7. Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study.
Toriola AT; Surcel HM; Calypse A; Grankvist K; Luostarinen T; Lukanova A; Pukkala E; Lehtinen M
Eur J Cancer; 2010 Oct; 46(15):2799-805. PubMed ID: 20601305
[TBL] [Abstract][Full Text] [Related]
8. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
9. Anti-Mullerian hormone and risk of invasive serous ovarian cancer.
Schock H; Lundin E; Vääräsmäki M; Grankvist K; Fry A; Dorgan JF; Pukkala E; Lehtinen M; Surcel HM; Lukanova A
Cancer Causes Control; 2014 May; 25(5):583-9. PubMed ID: 24562905
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study.
Toriola AT; Surcel HM; Lundin E; Schock H; Grankvist K; Pukkala E; Chen T; Toniolo P; Lehtinen M; Zeleniuch-Jacquotte A; Lukanova A
Cancer Causes Control; 2011 Nov; 22(11):1607-11. PubMed ID: 21833488
[TBL] [Abstract][Full Text] [Related]
11. Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Kaaks R; Rinaldi S; Helzlsouer KJ
Int J Cancer; 2009 Aug; 125(3):674-9. PubMed ID: 19444906
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and risk of ovarian cancer: A systematic review and meta-analysis.
Li J; Jiao X; Yuan Z; Qiu H; Guo R
Medicine (Baltimore); 2017 Aug; 96(34):e7822. PubMed ID: 28834887
[TBL] [Abstract][Full Text] [Related]
13. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia.
Qiu C; Luthy DA; Zhang C; Walsh SW; Leisenring WM; Williams MA
Am J Hypertens; 2004 Feb; 17(2):154-60. PubMed ID: 14751658
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).
Lundin E; Dossus L; Clendenen T; Krogh V; Grankvist K; Wulff M; Sieri S; Arslan AA; Lenner P; Berrino F; Hallmans G; Zeleniuch-Jacquotte A; Toniolo P; Lukanova A
Cancer Causes Control; 2009 Sep; 20(7):1151-9. PubMed ID: 19301134
[TBL] [Abstract][Full Text] [Related]
16. Circulating soluble Fas levels and risk of ovarian cancer.
Akhmedkhanov A; Lundin E; Guller S; Lukanova A; Micheli A; Ma Y; Afanasyeva Y; Zeleniuch-Jacquotte A; Krogh V; Lenner P; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
BMC Cancer; 2003 Dec; 3():33. PubMed ID: 14690548
[TBL] [Abstract][Full Text] [Related]
17. Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer.
Jeong NH; Song ES; Lee JM; Lee KB; Kim MK; Cheon JE; Lee JK; Son SK; Lee JP; Kim JH; Hur SY; Kwon YI
Acta Obstet Gynecol Scand; 2009; 88(4):457-62. PubMed ID: 19266359
[TBL] [Abstract][Full Text] [Related]
18. [Changes in calprotectin concentration--inflammation marker in serum of women with gynecological cancer].
Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Nocoń M
Ginekol Pol; 2011 Nov; 82(11):822-6. PubMed ID: 22384614
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
[TBL] [Abstract][Full Text] [Related]
20. Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort.
Canetta S; Sourander A; Surcel HM; Hinkka-Yli-Salomäki S; Leiviskä J; Kellendonk C; McKeague IW; Brown AS
Am J Psychiatry; 2014 Sep; 171(9):960-8. PubMed ID: 24969261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
